Search Results - "Jung, Gi Mo"
-
1
Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers
Published in Antimicrobial agents and chemotherapy (01-06-2017)“…This study was a phase 1, single-center, randomized, double-blind, placebo-controlled, single-dosing, and dose-escalating study of intravenous SAL200. It is a…”
Get full text
Journal Article -
2
Preclinical Safety Evaluation of Intravenously Administered SAL200 Containing the Recombinant Phage Endolysin SAL-1 as a Pharmaceutical Ingredient
Published in Antimicrobial agents and chemotherapy (01-04-2014)“…Phage endolysins have received increasing attention as potent antibacterial agents. However, although safety evaluation is a prerequisite for the drug…”
Get full text
Journal Article -
3
Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1
Published in International journal of antimicrobial agents (01-02-2013)“…Abstract To evaluate the phage endolysin SAL-1 as a therapeutic agent for Staphylococcus aureus infections, the in vitro and in vivo antibacterial properties…”
Get full text
Journal Article -
4
Characterisation of the antibacterial properties of the recombinant phage endolysins AP50-31 and LysB4 as potent bactericidal agents against Bacillus anthracis
Published in Scientific reports (08-01-2018)“…The recombinant phage endolysins AP50-31 and LysB4 were developed using genetic information from bacteriophages AP50 and B4 and were produced by microbial…”
Get full text
Journal Article -
5
Comparison of the Antibacterial Properties of Phage Endolysins SAL-1 and LysK
Published in Antimicrobial Agents and Chemotherapy (01-04-2011)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
6
Pharmacokinetics of the phage endolysin-based candidate drug SAL200 in monkeys and its appropriate intravenous dosing period
Published in Clinical and experimental pharmacology & physiology (01-10-2016)“…Summary SAL200 is a new phage endolysin‐based candidate drug for the treatment of staphylococcal infections. An intravenous administration study was conducted…”
Get full text
Journal Article -
7
Pharmacokinetics of the phage endolysin‐based candidate drug SAL 200 in monkeys and its appropriate intravenous dosing period
Published in Clinical and experimental pharmacology & physiology (01-10-2016)“…SAL 200 is a new phage endolysin‐based candidate drug for the treatment of staphylococcal infections. An intravenous administration study was conducted in…”
Get full text
Journal Article -
8
Repeated injection of KMRC011, a medical countermeasure for radiation, can cause adverse health effects in cynomolgus monkeys
Published in Journal of applied toxicology (01-02-2019)“…High‐dose radiation‐induced tissue damage is a major limiting factor in the medical application of nuclear technology. Herein, we tested 28‐day repeated‐dose…”
Get full text
Journal Article